FDA panel weighs Covid vaccines and boosters; majority of data used in health care AI comes from U.S., China

STAT's Andrew Joseph and Matthew Herper are live-blogging the meeting of an FDA advisory committee on second boosters and more. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Tracking an FDA advisory panel meeting on Covid-19 vaccines and boosters By Andrew Joseph and Matthew Herper JOEL SAGET/AFP via Getty Images STAT will be live-blogging the all-day meeting of the Vaccines and Related Biological Products Advisory Committee, or VRBPAC. Read More STAT+: STAT-Harris Poll: Most Americans would get a Covid-19 booster shot if recommended By Ed Silverman Eugene Hoshiko/AP A new poll of U.S. adults finds six in 10 have already decided they will get a booster if it's recommended for them. Read More 'We need to be much more diverse': More than half of data used in health care AI comes from the U.S. and China By Katie Palmer Adobe A review of more than 7,000 clinical AI papers found more than half of the databases used in the work came from the U.S. and China. Read More Sponsor content by STAT Events Battle scars: The journey from lab to patient's bedside Join STAT on May 3 in Boston to explore the challenges, and the unique opportunities for new approaches, solutions, and partnerships, of the drug development process. This in-person program will bring together a diverse group of individuals to share their perspectives about the drug development process. Stay once the conversation is complete for a networking and cocktail reception with STAT and your fellow attendees. Get your ticket now (and save 40% as a STAT+ subscriber). STAT+: Virtual reality in medicine is garnering more investment. Will the health care system buy in? By Mohana Ravindranath Adobe Virtual reality companies are clearing early regulatory hurdles to use immersive technology to help patients manage conditions. Read More Opinion: Listen: Should gender dysphoria be a required stop en route to gender euphoria? By Patrick Skerrett This week, "The First Opinion Podcast" explores why a diagnosis of "gender dysphoria" shouldn't be needed to cover gender-affirming care. Read More Opinion: Report: U.S. nursing home care is ineffective, inefficient, inequitable, fragmented, and unsustainable By David C. Grabowski and Marilyn Rantz and Jasmine L. Travers Michael Probst/AP A new report from the National Academies of Sciences, Engineering, and Medicine examines the plight of nursing home care in the U.S. Read More Opinion: STAT+: Reimagining R&D can cut drug development costs from billions to millions By Nicole Paraggio and Nicole van Poppel and Selen Karaca-Griffin Abobe Transforming R&D has a pivotal role to play in exponentially reducing the cost of discovering and developing new drugs. Read More Wednesday, April 6, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser